These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33229317)

  • 61. An Intronic Risk SNP rs12454712 for Central Obesity Acts As an Allele-Specific Enhancer To Regulate
    Dong SS; Zhu DL; Zhou XR; Rong Y; Zeng M; Chen JB; Jiang F; Tuo XM; Feng Z; Yang TL; Guo Y
    Diabetes; 2021 Aug; 70(8):1679-1688. PubMed ID: 34035043
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Integrated enhancer regulatory network by enhancer-promoter looping in gastric cancer.
    Zhu T; Okabe A; Usui G; Fujiki R; Komiyama D; Huang KK; Seki M; Fukuyo M; Abe H; Ning M; Okada T; Minami M; Matsumoto M; Fan Q; Rahmutulla B; Hoshii T; Tan P; Morikawa T; Ushiku T; Kaneda A
    NAR Cancer; 2024 Jun; 6(2):zcae020. PubMed ID: 38720882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Methylation Status of Apoptosis Genes and Intensity of Apoptotic Death of Peripheral Blood Lymphocytes in Persons Chronically Exposed to Radiation].
    Blinova EA; Nikiforov VS; Kotikova AI; Yanishevskaya MA; Akleyev AV
    Mol Biol (Mosk); 2022; 56(6):1072-1082. PubMed ID: 36475490
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The transcriptional complex between the BCL2 i-motif and hnRNP LL is a molecular switch for control of gene expression that can be modulated by small molecules.
    Kang HJ; Kendrick S; Hecht SM; Hurley LH
    J Am Chem Soc; 2014 Mar; 136(11):4172-85. PubMed ID: 24559432
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer.
    Berger S; Procko E; Margineantu D; Lee EF; Shen BW; Zelter A; Silva DA; Chawla K; Herold MJ; Garnier JM; Johnson R; MacCoss MJ; Lessene G; Davis TN; Stayton PS; Stoddard BL; Fairlie WD; Hockenbery DM; Baker D
    Elife; 2016 Nov; 5():. PubMed ID: 27805565
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Noxa and Puma genes regulated by hTERT promoter can mitigate growth and induce apoptosis in hepatocellular carcinoma mouse model.
    Zhao T; Zhao C; Lu Y; Lin J; Tian Y; Ma Y; Li J; Zhang H; Yan W; Jiao P; Ma J
    J Cancer; 2022; 13(6):2001-2013. PubMed ID: 35399714
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Galactosylceramide Upregulates the Expression of the
    Suchanski J; Reza S; Urbaniak A; Woldanska W; Kocbach B; Ugorski M
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254878
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation.
    Lowthert L; Leffert J; Lin A; Umlauf S; Maloney K; Muralidharan A; Lorberg B; Mane S; Zhao H; Sinha R; Bhagwagar Z; Beech R
    Biol Mood Anxiety Disord; 2012 Sep; 2():15. PubMed ID: 22967286
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias.
    Tzifi F; Economopoulou C; Gourgiotis D; Ardavanis A; Papageorgiou S; Scorilas A
    Adv Hematol; 2012; 2012():524308. PubMed ID: 21941553
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The importance of transmembrane domain interactions in the viral control of apoptosis.
    Duart G; Mingarro I; Martinez-Gil L
    Mol Cell Oncol; 2021; 8(3):1911290. PubMed ID: 34027047
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correction to "The Dynamic Character of the BCL2 Promoter i-Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the Alternative DNA Hairpin Structure".
    Kendrick S; Kang HJ; Alam MP; Madathil MM; Agrawal P; Gokhale V; Yang D; Hecht SM; Hurley LH
    J Am Chem Soc; 2016 Sep; 138(35):11408. PubMed ID: 27571358
    [No Abstract]   [Full Text] [Related]  

  • 72. Correction to: Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2.
    Wang Y; Zhu L; Guo M; Sun G; Zhou K; Pang W; Cao D; Tang X; Meng X
    Cell Death Discov; 2021 Oct; 7(1):302. PubMed ID: 34675194
    [No Abstract]   [Full Text] [Related]  

  • 73. Author Correction: Viral Bcl2s' transmembrane domain interact with host Bcl2 proteins to control cellular apoptosis.
    García-Murria MJ; Duart G; Grau B; Diaz-Beneitez E; Rodríguez D; Mingarro I; Martínez-Gil L
    Nat Commun; 2021 Apr; 12(1):2246. PubMed ID: 33833241
    [No Abstract]   [Full Text] [Related]  

  • 74. [The NOXA promoter could function as an active enhancer to regulate the expression of BCL2 in the apoptosis response].
    Qin ZY; Shi X; Cao PP; Chu Y; Guan W; Yang N; Cheng H; Sun YJ
    Yi Chuan; 2020 Nov; 42(11):1110-1121. PubMed ID: 33229317
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SATB1 Mediates Long-Range Chromatin Interactions: A Dual Regulator of Anti-Apoptotic BCL2 and Pro-Apoptotic NOXA Genes.
    Yang Y; Wang Z; Sun L; Shao L; Yang N; Yu D; Zhang X; Han X; Sun Y
    PLoS One; 2015; 10(9):e0139170. PubMed ID: 26422397
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3'-UTR.
    Gong F; Sun L; Wang Z; Shi J; Li W; Wang S; Han X; Sun Y
    Nucleic Acids Res; 2011 Jun; 39(11):4640-52. PubMed ID: 21310710
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aberrant activation of CYR61 enhancers in colorectal cancer development.
    Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
    J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factors and Mechanisms That Influence Chromatin-Mediated Enhancer-Promoter Interactions and Transcriptional Regulation.
    Ito S; Das ND; Umehara T; Koseki H
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358822
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.